HSD3B1 Variants Linked With Outcomes of Prostate Cancer Treatments - Cancer Network
[unable to retrieve full-text content]HSD3B1 Variants Linked With Outcomes of Prostate Cancer Treatments Cancer Network
https://ift.tt/2Xsc8gf
HSD3B1 genotype may be a predictive biomarker for the use of androgen deprivation therapy (ADT) or abiraterone in Japanese men with prostate cancer, ...
https://ift.tt/2Xsc8gf
Comments
Post a Comment